Header cover image

Chinese (SSE) Biotech Industry Analysis

UpdatedJul 16, 2024
DataAggregated Company Financials
Companies73
  • 7D3.1%
  • 3M-9.0%
  • 1Y-22.5%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 2.6%, driven by a pullback from Chongqing Zhifei Biological Products of 4.7%. In contrast, Gan & Lee Pharmaceuticals has gained 7.1%. Overall the industry is down 25% in 12 months. As for the next few years, earnings are expected to grow by 32% per annum.

Industry Valuation and Performance

Has the Chinese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Jul 2024CN¥824.7bCN¥161.1bCN¥17.3b32.2x47.7x5.1x
Thu, 13 Jun 2024CN¥890.9bCN¥161.1bCN¥17.3b33.3x51.5x5.5x
Sat, 11 May 2024CN¥979.5bCN¥161.1bCN¥17.3b38.3x56.8x6.1x
Mon, 08 Apr 2024CN¥965.0bCN¥161.0bCN¥20.1b39.9x47.9x6x
Wed, 06 Mar 2024CN¥1.0tCN¥165.5bCN¥22.0b35.5x45.8x6.1x
Fri, 02 Feb 2024CN¥880.0bCN¥167.9bCN¥21.4b31.6x41.1x5.2x
Sun, 31 Dec 2023CN¥1.1tCN¥168.1bCN¥21.5b40.6x52.3x6.7x
Tue, 28 Nov 2023CN¥1.1tCN¥168.1bCN¥21.5b40.7x52.5x6.7x
Thu, 26 Oct 2023CN¥1.0tCN¥169.5bCN¥23.7b38.6x42.6x6x
Sat, 23 Sep 2023CN¥1.0tCN¥170.9bCN¥25.2b39.3x41.1x6.1x
Mon, 21 Aug 2023CN¥1.0tCN¥173.7bCN¥28.2b37.6x36.2x5.9x
Wed, 19 Jul 2023CN¥1.1tCN¥177.4bCN¥29.9b38.4x35.5x6x
Fri, 16 Jun 2023CN¥1.1tCN¥177.4bCN¥29.3b39.3x37.2x6.1x
Sun, 14 May 2023CN¥1.1tCN¥177.7bCN¥29.6b40.7x38.8x6.5x
Tue, 11 Apr 2023CN¥1.3tCN¥186.1bCN¥36.4b43x35.1x6.9x
Thu, 09 Mar 2023CN¥1.3tCN¥178.9bCN¥36.0b44.1x34.9x7x
Sat, 04 Feb 2023CN¥1.3tCN¥179.6bCN¥37.9b44.1x34.9x7.4x
Mon, 02 Jan 2023CN¥1.2tCN¥175.6bCN¥37.9b38.7x32x6.9x
Wed, 30 Nov 2022CN¥1.3tCN¥175.5bCN¥37.9b39.1x33.7x7.3x
Fri, 28 Oct 2022CN¥1.2tCN¥177.1bCN¥41.1b35.4x28.8x6.7x
Sun, 25 Sep 2022CN¥1.1tCN¥174.0bCN¥40.1b29.6x27.6x6.4x
Tue, 23 Aug 2022CN¥1.2tCN¥173.0bCN¥43.2b36.7x28.8x7.2x
Thu, 21 Jul 2022CN¥1.3tCN¥168.3bCN¥42.5b37x30.8x7.8x
Sat, 18 Jun 2022CN¥1.3tCN¥168.1bCN¥42.4b38.2x30.3x7.6x
Mon, 16 May 2022CN¥1.2tCN¥168.1bCN¥42.4b35.4x29.4x7.4x
Wed, 13 Apr 2022CN¥1.4tCN¥153.2bCN¥40.8b40x34.7x9.2x
Fri, 11 Mar 2022CN¥1.4tCN¥152.2bCN¥40.8b45x33.4x9x
Sun, 06 Feb 2022CN¥1.4tCN¥143.8bCN¥38.7b43.1x35x9.4x
Tue, 04 Jan 2022CN¥1.5tCN¥141.8bCN¥38.5b50.6x40x10.9x
Thu, 02 Dec 2021CN¥1.6tCN¥145.1bCN¥40.2b51x40.3x11.2x
Sat, 30 Oct 2021CN¥1.5tCN¥137.7bCN¥37.8b45.5x40.8x11.2x
Mon, 27 Sep 2021CN¥1.6tCN¥130.3bCN¥33.4b46.9x47.1x12.1x
Wed, 25 Aug 2021CN¥1.7tCN¥130.3bCN¥33.4b49.6x50.6x13x
Price to Earnings Ratio

55.3x


Total Market Cap: CN¥1.8tTotal Earnings: CN¥33.4bTotal Revenue: CN¥130.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Biotech Industry Price to Earnings3Y Average 39.2x202220232024
Current Industry PE
  • Investors are optimistic on the Chinese Biotechnology industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 46.6x which is higher than its 3-year average PE of 39.1x.
  • The 3-year average PS ratio of 7.6x is higher than the industry's current PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have declined 20% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Biotech compare with similar industries?

CN Market2.20%
Healthcare1.60%
Biotech3.11%
Biotech3.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603392 Beijing Wantai Biological Pharmacy EnterpriseCN¥70.046.7%
+CN¥5.6b
9.1%PE691.4x
002007 Hualan Biological EngineeringCN¥16.599.5%
+CN¥2.6b
-23.5%PE21.8x
300896 Imeik Technology DevelopmentLtdCN¥166.205.1%
+CN¥2.4b
-47.6%PE25.4x
300122 Chongqing Zhifei Biological ProductsCN¥26.812.8%
+CN¥1.7b
-41.8%PE8.6x
600161 Beijing Tiantan Biological ProductsCN¥24.643.1%
+CN¥1.5b
19.6%PE41.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

603392

CN¥70.04

Beijing Wantai Biological Pharmacy Enterprise

7D

6.7%

1Y

9.1%

000403

CN¥26.54

Pacific Shuanglin Bio-pharmacy

7D

-5.7%

1Y

36.4%

301301

CN¥12.46

Yili Chuanning BiotechnologyLtd

7D

-0.5%

1Y

41.4%

002007

CN¥16.59

Hualan Biological Engineering

7D

9.5%

1Y

-23.5%

300122

CN¥26.81

Chongqing Zhifei Biological Products

7D

2.8%

1Y

-41.8%

000518

CN¥1.84

Jiangsu Sihuan Bioengineering

7D

-7.5%

1Y

-29.0%

002252

CN¥7.88

Shanghai RAAS Blood Products

7D

2.7%

1Y

3.7%

688276

CN¥29.67

Changchun BCHT Biotechnology

7D

-0.8%

1Y

-49.2%

688520

CN¥40.87

Sinocelltech Group

7D

5.7%

1Y

-28.7%

600201

CN¥6.59

Jinyu Bio-technology

7D

-1.2%

1Y

-31.5%

688363

CN¥59.50

Bloomage BioTechnology

7D

-0.7%

1Y

-33.9%

688278

CN¥55.79

Xiamen Amoytop Biotech

7D

4.8%

1Y

33.9%

600161

CN¥24.64

Beijing Tiantan Biological Products

7D

3.1%

1Y

19.6%